Description
Plus: Home-building slowed more than expected in August. And Eli Lilly says its investigational diabetes pill outperformed Novo Nordisk’s oral semaglutide in a clinical trial. Zoe Kuhlkin hosts. Learn more about your ad choices. Visit megaphone.fm/adchoices
Audio
Featured in this Episode
No persons identified in this episode.
Transcription
No transcription available yet
Help us prioritize this episode for transcription by upvoting it.
0
upvotes
Popular episodes get transcribed faster